This protein is the receptor for the cytotoxic ligand TNFSF10/TRAIL. It lacks a cytoplasmic death domain and hence is not capable of inducing apoptosis nor can it induce the NF-kappa-B pathway. It protects cells against TRAIL mediated apoptosis possibly through ligand competition.
Citations
Publication ()
Have you cited DCABH-17173 in a publication? Let us know and earn a reward for your research.
My Review for Anti-TNFRSF22 monoclonal antibody, clone Mvdz-2
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.